L-Alanyl-L-Glutamine Production Cost Reports

The report provides a detailed analysis essential for establishing a L-Alanyl-L-glutamine production plant. It encompasses all critical aspects necessary for L-Alanyl-L-glutamine production, including the cost of L-Alanyl-L-glutamine production, L-Alanyl-L-glutamine plant cost, L-Alanyl-L-glutamine production costs, and the overall L-Alanyl-L-glutamine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a L-Alanyl-L-glutamine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

L-Alanyl-L-glutamine, a stable dipeptide form of glutamine, is utilised in biopharmaceutical production as a cell culture media supplement. It provides controlled glutamine release to enhance cell growth, boost therapeutic protein yields, and minimise toxic ammonia buildup while enabling media heat sterilisation and extended shelf-life at 4 degree Celsius.

It functions as a bioavailable component in parenteral and enteral nutrition in the nutritional and medical sectors for critically ill patients, including those post-surgery, with severe burns, trauma, or undergoing chemotherapy. It supports gut health, immune function, nitrogen balance, muscle recovery, and wound healing without tissue accumulation. Additionally, its high solubility and thermostability make it suitable for pharmaceutical drug formulations and dietary supplements, with ongoing biotechnological advancements like enzymatic synthesis using immobilised microbes.

The market demand for L-Alanyl-L-glutamine is driven by expanding demand in pharmaceuticals for critical care nutrition, mainly parenteral formulations for post-surgical, trauma, and chemotherapy patients. The rising adoption of dietary supplements for muscle recovery, immune support, and sports nutrition, fuelled by global fitness awareness, also boosts the demand. Advancements in peptide synthesis technology enhance scalability and production efficiency, supporting biopharmaceutical cell culture media applications, while emerging uses in cosmetics for hydration, anti-ageing serums, and animal nutrition further boost opportunities.

Industrial L-Alanyl-L-glutamine procurement is influenced by its complex synthesis from upstream raw materials like L-alanine and L-glutamine, which drives high production costs through enzymatic or chemical processes requiring specialised biotech facilities. Furthermore, stringent pharmaceutical GMP standards, regulatory approvals for medical-grade purity, and quality certifications elevate sourcing barriers and costs, which affect the overall procurement.

Raw Material for L-Alanyl-L-glutamine Production

According to the L-Alanyl-L-glutamine production plant project report, the various raw materials for L-Alanyl-L-glutamine production include D-2-chloro- or D-2-bromopropionic acid and thionyl chloride; L-alanine and L-glutamine.

Production Processes of L-Alanyl-L-glutamine

The extensive L-Alanyl-L-glutamine production cost report consists of the following major industrial production processes:

1. Production from chemical synthesis via Halogenated Intermediates: The production process for L-alanyl-L-glutamine involves reacting D-2-chloro- or D-2-bromopropionic acid with thionyl chloride to form the acid chloride. The reaction is followed by Schotten-Baumann acylation with L-glutamine to yield the intermediate D-2-halopropionyl-L-glutamine. The final step involves ammonolysis to achieve stereochemical inversion and dipeptide formation, producing L-alanyl-L-glutamine. The chloro intermediate has superior stability over the bromo analogue, requiring elevated temperatures for ammonolysis yet producing by-products with minimal impact on final product purity, which are subsequently removed via anion exchange resin treatment and recrystallisation.
2. Production via biotechnological and enzymatic methods: The production process of L-alanyl-L-glutamine via fermentative production employs genetically engineered Escherichia coli expressing L-amino acid α-ligase (Lal) to catalyse ATP-dependent condensation of L-alanine and L-glutamine. The process yields over 100 mM Ala-Gln extracellularly in fed-batch glucose-ammonium media without added substrates, avoiding longer peptides or D-amino acids. Enzymatic synthesis using thermostable enzymes couples L-alanine methyl ester with L-glutamine, while recycling whole-cell biocatalysts like E. coli enhances yields in greener processes.

Properties of L-Alanyl-L-glutamine

L-Alanyl-L-glutamine is a white to nearly white powder dipeptide with the molecular formula C8H15N3O4 and a molecular weight of 217.22 g/mol. It has a melting point in the range of 213–217 degree Celsius and has exceptional water solubility (586 g/L), significantly higher than free glutamine. The compound is chemically stable, including heat sterilisation up to 121 degree Celsius, with a pKa around 3.12 and a logP of -4.6, which makes it hydrophilic and suitable for aqueous formulations. It has a slightly acidic pH in solution (5.0–6.0), is hygroscopic, and shows a specific optical rotation confirming its stereochemistry.